0001593968-19-000213.txt : 20190124
0001593968-19-000213.hdr.sgml : 20190124
20190124160353
ACCESSION NUMBER: 0001593968-19-000213
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190122
FILED AS OF DATE: 20190124
DATE AS OF CHANGE: 20190124
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ZERBE ROBERT L MD
CENTRAL INDEX KEY: 0001220363
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35280
FILM NUMBER: 19540039
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Vericel Corp
CENTRAL INDEX KEY: 0000887359
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 943096597
STATE OF INCORPORATION: MI
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 64 SIDNEY ST.
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 7349305555
MAIL ADDRESS:
STREET 1: 64 SIDNEY ST.
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
FORMER COMPANY:
FORMER CONFORMED NAME: AASTROM BIOSCIENCES INC
DATE OF NAME CHANGE: 19960428
4
1
primary_01.xml
PRIMARY DOCUMENT
X0306
4
2019-01-22
0000887359
Vericel Corp
VCEL
0001220363
ZERBE ROBERT L MD
C/O VERICEL CORPORATION
64 SIDNEY STREET
CAMBRIDGE
MA
02139
true
false
false
false
Common Stock
2019-01-22
4
M
false
17500
2.63
A
17545
D
Stock Option (right to buy)
2.63
2019-01-22
4
M
false
17500
0
D
2027-05-03
Common Stock
17500
0
D
These options, representing the right to purchase a total of 17,500 shares, became exercisable in equal monthly installments, contingent upon continued service to the Company, with the first vesting date on June 3, 2017, which was one month after the date on which the option was granted.
/s/ Dominick C. Colangelo, Attorney-in-Fact for Robert Zerbe
2019-01-24